Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan I Silverberg

Showing results (281-290 of 667) with videos related to

Pageof 67
Sort By:
The Journal of Dermatological Treatment|June 1, 2023
Treatment preferences among patients with mild-to-moderate atopic dermatitisKelley Myers, Jonathan I Silverberg, Shreekant Parasuraman, et al.
The British Journal of Dermatology|September 2, 2025
Rademikibart monotherapy for moderate-to-severe atopic dermatitis in a 1-year, randomized, phase II trial (SEASIDE CHINA): initial two-week dosing, followed by two-week or four-week dosingJianzhong Zhang, Jonathan I Silverberg, Jiawang Guo, et al.
The Journal of Investigative Dermatology|August 1, 2014
Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based studyJonathan I Silverberg, Nitin K Garg, Amy S Paller, et al.
Human Vaccines & Immunotherapeutics|July 9, 2021
Factors impacting vaccine hesitancy toward Coronavirus disease-19 (COVID-19) vaccination in Brooklyn, New YorkTamar A Smith-Norowitz, Jonathan I Silverberg, Esther M Norowitz, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|February 17, 2026
Burden of Mild-to-Moderate Atopic Dermatitis in Adults in the United States: Results from the National Health and Wellness SurveyJonathan I Silverberg, Wendy Smith Begolka, Zelma C Chiesa Fuxench, et al.
Contact Dermatitis|January 5, 2025
Prevalence and Characteristics of Chronic Hand Eczema Among Adults in Denmark: A General Population-Based StudyDavid Thein, Julia-Tatjana Maul, Simone Ribero, et al.
The Journal of Allergy and Clinical Immunology|January 9, 2023
Comorbidities of atopic dermatitis-what does the evidence say?Jacob P Thyssen, Anne-Sofie Halling, Peter Schmid-Grendelmeier, et al.
Vaccine|March 2, 2021
Vaccines do not cause atopic dermatitis: A systematic review and meta-analysisMarissa Ayasse, Adnan Ahmed, Catherine McCullum, et al.
Pediatric Dermatology|August 2, 2021
TH2 sensitization in the skin-gut-brain axis: How early-life Th2-mediated inflammation may negatively perpetuate developmental and psychologic abnormalitiesLaDonya Jackson-Cowan, Emily F Cole, Jack L Arbiser, et al.
Journal of Drugs in Dermatology : JDD|May 3, 2011
Scalp hyperkeratosis and alopecia in children of colorMarcelyn K Coley, Dhaval G Bhanusali, Jonathan I Silverberg, et al.
Pageof 67

Showing results (281-290 of 667) with videos related to

Sort By:
Pageof 67
The Journal of Dermatological Treatment|June 1, 2023
Treatment preferences among patients with mild-to-moderate atopic dermatitisKelley Myers, Jonathan I Silverberg, Shreekant Parasuraman, et al.
The British Journal of Dermatology|September 2, 2025
Rademikibart monotherapy for moderate-to-severe atopic dermatitis in a 1-year, randomized, phase II trial (SEASIDE CHINA): initial two-week dosing, followed by two-week or four-week dosingJianzhong Zhang, Jonathan I Silverberg, Jiawang Guo, et al.
The Journal of Investigative Dermatology|August 1, 2014
Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based studyJonathan I Silverberg, Nitin K Garg, Amy S Paller, et al.
Human Vaccines & Immunotherapeutics|July 9, 2021
Factors impacting vaccine hesitancy toward Coronavirus disease-19 (COVID-19) vaccination in Brooklyn, New YorkTamar A Smith-Norowitz, Jonathan I Silverberg, Esther M Norowitz, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|February 17, 2026
Burden of Mild-to-Moderate Atopic Dermatitis in Adults in the United States: Results from the National Health and Wellness SurveyJonathan I Silverberg, Wendy Smith Begolka, Zelma C Chiesa Fuxench, et al.
Contact Dermatitis|January 5, 2025
Prevalence and Characteristics of Chronic Hand Eczema Among Adults in Denmark: A General Population-Based StudyDavid Thein, Julia-Tatjana Maul, Simone Ribero, et al.
The Journal of Allergy and Clinical Immunology|January 9, 2023
Comorbidities of atopic dermatitis-what does the evidence say?Jacob P Thyssen, Anne-Sofie Halling, Peter Schmid-Grendelmeier, et al.
Vaccine|March 2, 2021
Vaccines do not cause atopic dermatitis: A systematic review and meta-analysisMarissa Ayasse, Adnan Ahmed, Catherine McCullum, et al.
Pediatric Dermatology|August 2, 2021
TH2 sensitization in the skin-gut-brain axis: How early-life Th2-mediated inflammation may negatively perpetuate developmental and psychologic abnormalitiesLaDonya Jackson-Cowan, Emily F Cole, Jack L Arbiser, et al.
Journal of Drugs in Dermatology : JDD|May 3, 2011
Scalp hyperkeratosis and alopecia in children of colorMarcelyn K Coley, Dhaval G Bhanusali, Jonathan I Silverberg, et al.
Pageof 67